Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Harvard Business School
Merck
Boehringer Ingelheim
QuintilesIMS
Dow
McKinsey
Farmers Insurance

Generated: December 14, 2018

DrugPatentWatch Database Preview

Hydrocodone bitartrate; ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrocodone bitartrate; ibuprofen and what is the scope of hydrocodone bitartrate; ibuprofen patent protection?

Hydrocodone bitartrate; ibuprofen is the generic ingredient in three branded drugs marketed by Actavis Labs Fl Inc, Amneal Pharms Ny, Aurolife Pharma Llc, Sun Pharm Inds Inc, Teva, Vintage Pharms, and Abbvie, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for hydrocodone bitartrate; ibuprofen. Fourteen suppliers are listed for this compound.

Pharmacology for hydrocodone bitartrate; ibuprofen

US Patents and Regulatory Information for hydrocodone bitartrate; ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 077723-001 Nov 6, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 077723-002 Nov 6, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Ny HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 076642-002 Mar 18, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Ny HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 076642-001 Oct 12, 2004 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 091633-003 May 28, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 091633-002 May 28, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for hydrocodone bitartrate; ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cipla
Healthtrust
Colorcon
Chubb
Mallinckrodt
UBS
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.